{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:56:19Z","timestamp":1792292179099,"version":"4.4.0"},"reference-count":232,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"am","delay-in-days":675,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008875","name":"University of Akron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-2107619"],"award-info":[{"award-number":["CBET-2107619"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bpc.2021.106735","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:50:17Z","timestamp":1638294617000},"page":"106735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["A mechanistic survey of Alzheimer's disease"],"prefix":"10.1016","volume":"281","author":[{"given":"Yijing","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","article-title":"Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology","volume":"16","author":"Rahman","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"17","key":"10.1016\/j.bpc.2021.106735_bb0010","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1021\/bi052485f","article-title":"Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42","volume":"45","author":"Sato","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpc.2021.106735_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/0-387-23226-5_8","article-title":"Amyloid accumulation and pathogensis of Alzheimer\u2019s disease: significance of monomeric, oligomeric and fibrillar Abeta","volume":"38","author":"Glabe","year":"2005","journal-title":"Subcell. Biochem."},{"issue":"5580","key":"10.1016\/j.bpc.2021.106735_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.bpc.2021.106735_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbadis.2004.08.008","article-title":"Cultured cell and transgenic mouse models for tau pathology linked to beta-amyloid","volume":"1739","author":"Bloom","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","article-title":"The role of TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"21","author":"Mackenzie","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bpc.2021.106735_bb0035","doi-asserted-by":"crossref","first-page":"106665","DOI":"10.1016\/j.bpc.2021.106665","article-title":"Kinetics theories to understand the mechanism of aggregation of a protein and to design strategies for its inhibition","volume":"278","author":"Sharma","year":"2021","journal-title":"Biophys. Chem."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0040","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type II diabetes, and amyotrophic lateral sclerosis","volume":"121","author":"Nguyen","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bpc.2021.106735_bb0045","doi-asserted-by":"crossref","first-page":"106711","DOI":"10.1016\/j.bpc.2021.106711","article-title":"Transient disorder along pathways to amyloid","volume":"281","author":"Morgan","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2021.106735_bb0050","doi-asserted-by":"crossref","first-page":"106505","DOI":"10.1016\/j.bpc.2020.106505","article-title":"Visualizing and trapping transient oligomers in amyloid assembly pathways","volume":"268","author":"Cawood","year":"2021","journal-title":"Biophys. Chem."},{"issue":"34","key":"10.1016\/j.bpc.2021.106735_bb0055","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1039\/D0CC01551B","article-title":"High-resolution probing of early events in amyloid-\u03b2 aggregation related to Alzheimer\u2019s disease","volume":"56","author":"Sahoo","year":"2020","journal-title":"Chem. Commun."},{"issue":"34","key":"10.1016\/j.bpc.2021.106735_bb0060","doi-asserted-by":"crossref","first-page":"18680","DOI":"10.1002\/anie.202104497","article-title":"Cryo-electron microscopy imaging of Alzheimer\u2019s amyloid-beta 42 oligomer displayed on a functionally and structurally relevant scaffold","volume":"60","author":"Wu","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep11811","article-title":"High-resolution NMR characterization of low abundance oligomers of amyloid-\u03b2 without purification","volume":"5","author":"Kotler","year":"2015","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bpc.2021.106735_bb0070","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1039\/c3cp44448a","article-title":"Molecular interactions of Alzheimer amyloid-\u03b2 oligomers with neutral and negatively charged lipid bilayers","volume":"15","author":"Yu","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020575","article-title":"Polymorphic structures of Alzheimer\u2019s \u03b2-amyloid globulomers","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0080","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bpj.2010.05.006","article-title":"Structural determination of A\u03b225\u201335 micelles by molecular dynamics simulations","volume":"99","author":"Yu","year":"2010","journal-title":"Biophys. J."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0085","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1021\/acs.jctc.7b00495","article-title":"Fully atomistic A\u03b240 and A\u03b242 oligomers in water: Observation of porelike conformations","volume":"13","author":"Voelker","year":"2017","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bpc.2021.106735_bb0090","doi-asserted-by":"crossref","first-page":"101125","DOI":"10.1016\/j.nantod.2021.101125","article-title":"Spontaneous formation of \u03b2-sheet nano-barrels during the early aggregation of Alzheimer\u2019s amyloid beta","volume":"38","author":"Sun","year":"2021","journal-title":"Nano Today"},{"issue":"30","key":"10.1016\/j.bpc.2021.106735_bb0095","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1073\/pnas.0502066102","article-title":"Amyloid ion channels: a common structural link for protein-misfolding disease","volume":"102","author":"Quist","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0100","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1523\/JNEUROSCI.4771-07.2008","article-title":"Amyloid \u03b2 oligomers (A\u03b21\u201342 globulomer) suppress spontaneous synaptic activity by inhibition of P\/Q-type calcium currents","volume":"28","author":"Nimmrich","year":"2008","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0361-9230(00)00370-1","article-title":"Molecular mechanism of neurodegeneration induced by Alzheimer\u2019s \u03b2-amyloid protein: channel formation and disruption of calcium homeostasis","volume":"53","author":"Kawahara","year":"2000","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1085\/jgp.200609533","article-title":"Soluble amyloid oligomers increase bilayer conductance by altering dielectric structure","volume":"128","author":"Sokolov","year":"2006","journal-title":"J. General Physiol."},{"issue":"45","key":"10.1016\/j.bpc.2021.106735_bb0115","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-009-9033-1","article-title":"Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy","volume":"16","author":"Capone","year":"2009","journal-title":"Neurotox. Res."},{"issue":"5594","key":"10.1016\/j.bpc.2021.106735_bb0125","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bpc.2021.106735_bb0130","first-page":"1716","article-title":"Amyloid beta-peptide aggregation. What does it result in and how can it be prevented?","volume":"14","author":"Nerelius","year":"2008","journal-title":"Front. Biosci. (Landmark edition)"},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0135","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1074\/jbc.M606202200","article-title":"A ganglioside-induced toxic soluble A\u03b2 assembly: its enhanced formation from A\u03b2 bearing the Arctic mutation","volume":"282","author":"Yamamoto","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0140","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.bbamem.2007.07.001","article-title":"Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes","volume":"1768","author":"Brender","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.bpc.2021.106735_bb0145","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"A\u03b2 oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bpc.2021.106735_bb0150","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-\u03b2 protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2174\/156720508786898479","article-title":"Role of metal ions in the A\u03b2 oligomerization in Alzheimer\u2019s disease and in other neurological disorders","volume":"5","author":"Drago","year":"2008","journal-title":"Curr. Alzheimer Res."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nn0805-977","article-title":"The synaptic A\u03b2 hypothesis of Alzheimer disease","volume":"8","author":"Tanzi","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12035-014-8994-0","article-title":"The binding receptors of A\u03b2: an alternative therapeutic target for Alzheimer\u2019s disease","volume":"53","author":"Xia","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bpc.2021.106735_bb0170","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of A\u03b2 clearance and degradation by glial cells","volume":"8","author":"Ries","year":"2016","journal-title":"Front. Aging Neurosci."},{"issue":"s2","key":"10.1016\/j.bpc.2021.106735_bb0175","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.3233\/JAD-2010-100345","article-title":"Mitochondria dysfunction and neurodegenerative disorders: cause or consequence","volume":"20","author":"Morais","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.exger.2006.09.015","article-title":"Increased production of inflammatory cytokines in mild cognitive impairment","volume":"42","author":"Magaki","year":"2007","journal-title":"Exp. Gerontol."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0185","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ar200189b","article-title":"Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective","volume":"45","author":"Brender","year":"2012","journal-title":"Acc. Chem. Res."},{"issue":"33","key":"10.1016\/j.bpc.2021.106735_bb0190","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1002\/anie.200906670","article-title":"Amyloidogenic protein-membrane interactions: mechanistic insight from model systems","volume":"49","author":"Butterfield","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0195","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.bbamem.2018.04.002","article-title":"Structure of APP-C991\u201399 and implications for role of extra-membrane domains in function and oligomerization","volume":"1860","author":"Pantelopulos","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Biomembr."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt265","article-title":"Dietary regulation of PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer\u2019s disease","volume":"6","author":"Kitagishi","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0205","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arcmed.2012.10.015","article-title":"Deregulated Cdk5 activity is involved in inducing Alzheimer\u2019s disease","volume":"43","author":"Shukla","year":"2012","journal-title":"Arch. Med. Res."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0210","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0215","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3233\/JAD-2010-1317","article-title":"PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3\u03b2","volume":"19","author":"Qian","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205014666170417111859","article-title":"Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies","volume":"15","author":"Gao","year":"2018","journal-title":"Curr. Alzheimer Res."},{"issue":"10043","key":"10.1016\/j.bpc.2021.106735_bb0225","first-page":"505","article-title":"Flier Wiesje Maria. Alzheimer\u2019s disease","volume":"388","author":"Philip","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0199-x","article-title":"Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease","volume":"3","author":"Pooler","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0240","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/acschemneuro.8b00457","article-title":"Pathological changes of tau related to Alzheimer\u2019s disease","volume":"10","author":"Chu","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0245","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","article-title":"Acetylation of tau inhibits its degradation and contributes to tauopathy","volume":"67","author":"Min","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0250","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/hmg\/ddt402","article-title":"Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance","volume":"23","author":"Cook","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"42","key":"10.1016\/j.bpc.2021.106735_bb0255","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1021\/bi051028w","article-title":"Site-specific nitration differentially influences \u03c4 assembly in vitro","volume":"44","author":"Reynolds","year":"2005","journal-title":"Biochemistry"},{"issue":"1\u20133","key":"10.1016\/j.bpc.2021.106735_bb0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(02)02228-7","article-title":"Role of glycosylation in hyperphosphorylation of tau in Alzheimer\u2019s disease","volume":"512","author":"Liu","year":"2002","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0265","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm0896-871","article-title":"Glycosylation of microtubule\u2013associated protein tau: an abnormal posttranslational modification in Alzheimer\u2019s disease","volume":"2","author":"Wang","year":"1996","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0270","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-2008-14407","article-title":"Truncation of tau protein and its pathological significance in Alzheimer\u2019s disease","volume":"14","author":"Garcia-Sierra","year":"2008","journal-title":"J. Alzheimers Dis."},{"issue":"52","key":"10.1016\/j.bpc.2021.106735_bb0275","doi-asserted-by":"crossref","first-page":"54716","DOI":"10.1074\/jbc.M403364200","article-title":"Glycogen synthase kinase 3\u03b2 induces caspase-cleaved tau aggregation in situ","volume":"279","author":"Cho","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11062-019-09823-7","article-title":"Altered neurochemistry in Alzheimer\u2019s disease: targeting neurotransmitter receptor mechanisms and therapeutic strategy","volume":"51","author":"Kaur","year":"2019","journal-title":"Neurophysiology"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0285","first-page":"14","article-title":"Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer\u2019s disease: a review","volume":"27","author":"Svob Strac","year":"2015","journal-title":"Psychiatr. Danub."},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0290","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1185\/03007990903209332","article-title":"Cholinesterase inhibition: is there evidence for disease-modifying effects?","volume":"25","author":"Shanks","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0295","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/156720509787602915","article-title":"M1 agonists as a potential disease-modifying therapy for Alzheimer\u2019s disease","volume":"6","author":"Caccamo","year":"2009","journal-title":"Curr. Alzheimer Res."},{"issue":"4558","key":"10.1016\/j.bpc.2021.106735_bb0300","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.55782\/ane-2004-1495","article-title":"Alzheimer\u2019s disease and acetylcholine receptors","volume":"64","author":"Kihara","year":"2004","journal-title":"Acta Neurobiol. Exp."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0310","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JAD-2012-121447","article-title":"Modulation of \u03b17 nicotinic acetylcholine receptor and fibrillar amyloid-\u03b2 interactions in Alzheimer\u2019s disease brain","volume":"33","author":"Ni","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0315","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of Alzheimer\u2019s disease: an update","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann. Neurosci."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0320","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1172\/JCI27120","article-title":"Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A\u03b2 antibody","volume":"116","author":"Bales","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0325","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1073858404269012","article-title":"N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease","volume":"11","author":"Waxman","year":"2005","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0335","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer\u2019s disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0340","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/neu.480230915","article-title":"Excitotoxic cell death","volume":"23","author":"Choi","year":"1992","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.bpc.2021.106735_bb0345","first-page":"3","article-title":"Neuropathologic changes in Alzheimer\u2019s disease: potential targets for treatment","volume":"67","author":"Wenk","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bpc.2021.106735_bb0350","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/B978-0-444-64076-5.00026-0","article-title":"The genetic landscape of Alzheimer disease","volume":"148","author":"Carmona","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0355","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.32499","article-title":"Consortium, A. S. D. G. Genomic variants, genes, and pathways of Alzheimer\u2019s disease: an overview","volume":"174","author":"Naj","year":"2017","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0360","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ana.410430316","article-title":"Molecular mapping of Alzheimer-type dementia in Down\u2019s syndrome","volume":"43","author":"Prasher","year":"1998","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0365","first-page":"25","article-title":"Familial Alzheimer\u2019s disease in American descendants of the Volga Germans: probable genetic founder effect","volume":"23","author":"Bird","year":"1988","journal-title":"Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"issue":"5226","key":"10.1016\/j.bpc.2021.106735_bb0370","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/jnc.13535","article-title":"Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer\u2019s disease","volume":"137","author":"Somavarapu","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1299-4","article-title":"ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease","volume":"17","author":"Safieh","year":"2019","journal-title":"BMC Med."},{"issue":"43","key":"10.1016\/j.bpc.2021.106735_bb0385","doi-asserted-by":"crossref","first-page":"44795","DOI":"10.1074\/jbc.M408127200","article-title":"Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc","volume":"279","author":"Harris","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0390","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1194\/jlr.R075408","article-title":"The role of APOE on lipid homeostasis and inflammation in normal brains: Thematic Review Series: ApoE and Lipid Homeostasis in Alzheimer\u2019s Disease","volume":"58","author":"Rebeck","year":"2017","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.bpc.2021.106735_bb0395","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.bpc.2021.106735_bb0400","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0405","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2013.76","article-title":"The APOE \u03b54\/\u03b54 genotype potentiates vascular fibrin (ogen) deposition in amyloid-laden vessels in the brains of Alzheimer\u2019s disease patients","volume":"33","author":"Hultman","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"5","key":"10.1016\/j.bpc.2021.106735_bb0410","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biochi.2005.10.007","article-title":"Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes","volume":"88","author":"Rapp","year":"2006","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0415","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"issue":"7409","key":"10.1016\/j.bpc.2021.106735_bb0420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bpc.2021.106735_bb0425","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fmed.2018.00108","article-title":"The role of genetics in advancing precision medicine for Alzheimer\u2019s disease\u2014a narrative review","volume":"5","author":"Freudenberg-Hua","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.bpc.2021.106735_bb0430","doi-asserted-by":"crossref","first-page":"118627","DOI":"10.1016\/j.lfs.2020.118627","article-title":"Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer\u2019s disease","volume":"264","author":"Kesika","year":"2020","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0435","first-page":"2905","article-title":"Time to test antibacterial therapy in Alzheimer\u2019s disease","volume":"142","author":"Panza","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.bpc.2021.106735_bb0440","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fnagi.2018.00224","article-title":"Can an infection hypothesis explain the beta amyloid hypothesis of Alzheimer\u2019s disease?","volume":"10","author":"Fulop","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0445","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12551-019-00526-1","article-title":"Microbial functional amyloids serve diverse purposes for structure, adhesion and defence","volume":"11","author":"Shanmugam","year":"2019","journal-title":"Biophys. Rev."},{"issue":"18","key":"10.1016\/j.bpc.2021.106735_bb0450","doi-asserted-by":"crossref","first-page":"2001299","DOI":"10.1002\/advs.202001299","article-title":"Accelerated amyloid beta pathogenesis by bacterial amyloid FapC","volume":"7","author":"Javed","year":"2020","journal-title":"Adv. Sci."},{"issue":"23","key":"10.1016\/j.bpc.2021.106735_bb0455","doi-asserted-by":"crossref","first-page":"12317","DOI":"10.1039\/D0NR02710C","article-title":"Elevated amyloidoses of human IAPP and amyloid beta by lipopolysaccharide and their mitigation by carbon quantum dots","volume":"12","author":"Koppel","year":"2020","journal-title":"Nanoscale"},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0460","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1474-4422(18)30316-8","article-title":"Herpes viruses and Alzheimer\u2019s disease: new evidence in the debate","volume":"17","author":"Balin","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bpc.2021.106735_bb0465","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5","article-title":"Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: cross-seeding of dissimilar amyloid sequences","volume":"1","author":"Hartman","year":"2013","journal-title":"PeerJ"},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0470","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bpj.2009.08.034","article-title":"Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion","volume":"97","author":"Brender","year":"2009","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0475","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau3333","article-title":"Porphyromonas gingivalis in Alzheimer\u2019s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors","volume":"5","author":"Dominy","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep30028","article-title":"Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer\u2019s disease","volume":"6","author":"Minter","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0485","article-title":"Alzheimer's disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimer's Dementia: Translat. Res. Clin. Intervent."},{"issue":"11","key":"10.1016\/j.bpc.2021.106735_bb0490","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jalz.2019.09.075","article-title":"The path forward in Alzheimer\u2019s disease therapeutics: Reevaluating the amyloid cascade hypothesis","volume":"16","author":"Tolar","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bpc.2021.106735_bb0495","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3233\/JAD-150652","article-title":"T. Protective effect of amyloid-\u03b2 peptides against herpes simplex virus-1 infection in a neuronal cell culture model","volume":"50","author":"Bourgade","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0500","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10522-014-9538-8","article-title":"\u03b2-Amyloid peptides display protective activity against the human Alzheimer\u2019s disease-associated herpes simplex virus-1","volume":"16","author":"Bourgade","year":"2015","journal-title":"Biogerontology"},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer\u2019s disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.bpc.2021.106735_bb0510","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.1219059110","article-title":"Common mechanism unites membrane poration by amyloid and antimicrobial peptides","volume":"110","author":"Last","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bpc.2021.106735_bb0515","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3233\/JAD-171133","article-title":"Alzheimer\u2019s amyloid-\u03b2 is an antimicrobial peptide: a review of the evidence","volume":"62","author":"Gosztyla","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"14","key":"10.1016\/j.bpc.2021.106735_bb0520","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.3390\/ijms21144920","article-title":"The use of antimicrobial and antiviral drugs in Alzheimer\u2019s disease","volume":"21","author":"Iqbal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"38","key":"10.1016\/j.bpc.2021.106735_bb0525","doi-asserted-by":"crossref","first-page":"35019","DOI":"10.1074\/jbc.M203518200","article-title":"Stimulation of enveloped virus infection by \u03b2-amyloid fibrils","volume":"277","author":"Wojtowicz","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0530","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2007.10.007","article-title":"New structures help the modeling of toxic amyloid-[beta] ion channels","volume":"33","author":"Jang","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bpc.2021.106735_bb0535","doi-asserted-by":"crossref","first-page":"106700","DOI":"10.1016\/j.bpc.2021.106700","article-title":"Disorder-to-order transition of the amyloid-\u03b2 peptide upon lipid binding","volume":"280","author":"Fatafta","year":"2021","journal-title":"Biophys. Chem."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0540","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bpj.2012.06.045","article-title":"Two-step mechanism of membrane disruption by A\u03b2 through membrane fragmentation and pore formation","volume":"103","author":"Sciacca","year":"2012","journal-title":"Biophys. J."},{"issue":"19","key":"10.1016\/j.bpc.2021.106735_bb0545","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1039\/C3CS60431D","article-title":"Differences between amyloid-\u03b2 aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer\u2019s disease","volume":"43","author":"Kotler","year":"2014","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0550","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/13506120209072440","article-title":"Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense","volume":"9","author":"Hirakura","year":"2002","journal-title":"Amyloid"},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007358","article-title":"Antimicrobial activity of human prion protein is mediated by its N-terminal region","volume":"4","author":"Pasupuleti","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2021.106735_bb0560","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1039\/D0TB02958K","article-title":"Dual amyloid cross-seeding reveals steric zipper-facilitated fibrillization and pathological links between protein misfolding diseases","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"38","key":"10.1016\/j.bpc.2021.106735_bb0565","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1039\/C4SM00907J","article-title":"Molecular understanding of a potential functional link between antimicrobial and amyloid peptides","volume":"10","author":"Zhang","year":"2014","journal-title":"Soft Matter"},{"key":"10.1016\/j.bpc.2021.106735_bb0570","doi-asserted-by":"crossref","first-page":"2102978","DOI":"10.1002\/adfm.202102978","article-title":"Design and engineering of amyloid aggregation-prone fragments and their antimicrobial conjugates with multi-target functionality","volume":"31","author":"Zhang","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"7","key":"10.1016\/j.bpc.2021.106735_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101364","article-title":"Alzheimer\u2019s associated \u03b2-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes","volume":"9","author":"White","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0580","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0585","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/mp200419b","article-title":"Antimicrobial properties of amyloid peptides","volume":"9","author":"Kagan","year":"2012","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bpc.2021.106735_bb0590","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.bpj.2011.01.072","article-title":"Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link","volume":"100","author":"Jang","year":"2011","journal-title":"Biophys. J."},{"issue":"6093","key":"10.1016\/j.bpc.2021.106735_bb0595","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1218831","article-title":"Human \u03b1-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets","volume":"337","author":"Chu","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0600","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1529\/biophysj.108.128710","article-title":"Amyloid-type fiber formation in control of enzyme action: interfacial activation of phospholipase A2","volume":"95","author":"Code","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.bpc.2021.106735_bb0605","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1039\/D1SC01133B","article-title":"Antimicrobial \u03b1-defensins as multi-target inhibitors against amyloid formation and microbial infection","volume":"12","author":"Zhang","year":"2021","journal-title":"Chem. Sci."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0610","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.bbamem.2006.03.037","article-title":"Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: Implications for a novel mechanism of action","volume":"1758","author":"Zhao","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0615","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cbic.201500518","article-title":"The amyloid fibril-forming properties of the amphibian antimicrobial peptide uperin 3.5","volume":"17","author":"Calabrese","year":"2016","journal-title":"ChemBioChem"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0620","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-5793(89)81230-X","article-title":"Spontaneous polymerization of the antibiotic peptide magainin 2","volume":"247","author":"Urrutia","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bpc.2021.106735_bb0625","doi-asserted-by":"crossref","first-page":"526459","DOI":"10.3389\/fcimb.2020.526459","article-title":"The reversible non-covalent aggregation into fibers of PGLa and Magainin 2 preserves their antimicrobial activity and synergism","volume":"10","author":"Juhl","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075528","article-title":"Biophysical investigation of the membrane-disrupting mechanism of the antimicrobial and amyloid-like peptide dermaseptin S9","volume":"8","author":"Caillon","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1313-3","article-title":"Inflammation: the link between comorbidities, genetics, and Alzheimer\u2019s disease","volume":"15","author":"Newcombe","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0640","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/nbdi.2000.0321","article-title":"Costimulatory effects of interferon-\u03b3 and interleukin-1\u03b2 or tumor necrosis factor \u03b1 on the synthesis of A\u03b21-40 and A\u03b21-42 by human astrocytes","volume":"7","author":"Blasko","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bpc.2021.106735_bb0645","first-page":"575","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimer\u2019s Dementia: Translat. Res. Clin. Intervent."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0650","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","article-title":"Increased risk of type 2 diabetes in Alzheimer disease","volume":"53","author":"Janson","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0655","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1567205043480555","article-title":"The clinical and biological relationship between type II diabetes mellitus and Alzheimers disease","volume":"1","author":"Nicolls","year":"2004","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0660","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0665","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"35","key":"10.1016\/j.bpc.2021.106735_bb0670","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/epirev\/mxs012","article-title":"Type 2 diabetes as a risk factor for Alzheimer\u2019s disease: the confounders, interactions, and neuropathology associated with this relationship","volume":"35","author":"Vagelatos","year":"2013","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.bpc.2021.106735_bb0675","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.biopha.2018.12.101","article-title":"Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer\u2019s disease, Parkinson\u2019s disease","volume":"111","author":"Tan","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0680","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"17","key":"10.1016\/j.bpc.2021.106735_bb0685","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1093\/hmg\/dds215","article-title":"Amyloid precursor protein (APP) contributes to pathology in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"21","author":"Bryson","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bpc.2021.106735_bb0690","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","article-title":"Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment","volume":"10","author":"Li","year":"2015","journal-title":"Clin. Interv. Aging"},{"issue":"17","key":"10.1016\/j.bpc.2021.106735_bb0695","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/anie.200904902","article-title":"Identification of hot regions of the A beta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association","volume":"49","author":"Andreetto","year":"2010","journal-title":"Angew. Chem.-Int. Ed."},{"issue":"11","key":"10.1016\/j.bpc.2021.106735_bb0700","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1523\/JNEUROSCI.15-11-07625.1995","article-title":"Islet amyloid polypeptide (amylin) is expressed in sensory neurons","volume":"15","author":"Mulder","year":"1995","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bpc.2021.106735_bb0705","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0710","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneur.62.2.330-a","article-title":"Diabetes mellitus and Alzheimer disease","volume":"62","author":"Franco","year":"2005","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.bpc.2021.106735_bb0715","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archneur.63.11.1551","article-title":"Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study","volume":"63","author":"Akomolafe","year":"2006","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0720","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/15672050113109990009","article-title":"Alzheimer disease and diabetes mellitus: do they have anything in common?","volume":"10","author":"Adeghate","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0725","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/18715273113126660167","article-title":"Current view from Alzheimer disease to type 2 diabetes mellitus","volume":"13","author":"Rasool","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0730","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1471-4159.1993.tb07480.x","article-title":"Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer\u2019s disease amyloid-beta neurotoxicity","volume":"61","author":"May","year":"1993","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bpc.2021.106735_bb0735","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","article-title":"Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin","volume":"19","author":"Banks","year":"1998","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0740","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jchemneu.2004.03.005","article-title":"In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain","volume":"27","author":"Paxinos","year":"2004","journal-title":"J. Chem. Neuroanat."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0745","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0026-895X(25)13212-4","article-title":"High-affinity amylin binding-sites in rat-brain","volume":"44","author":"Beaumont","year":"1993","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0750","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-8993(00)03070-5","article-title":"Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain","volume":"887","author":"Arnelo","year":"2000","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0755","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0760","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1084\/jem.20161134","article-title":"Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism","volume":"214","author":"Mukherjee","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7568","key":"10.1016\/j.bpc.2021.106735_bb0765","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bpc.2021.106735_bb0770","doi-asserted-by":"crossref","first-page":"a024315","DOI":"10.1101\/cshperspect.a024315","article-title":"Prion-like protein aggregates and type 2 diabetes","volume":"7","author":"Mukherjee","year":"2017","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0775","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/nbdi.2000.0290","article-title":"Evidence for oxidative stress in experimental prion disease","volume":"7","author":"Guentchev","year":"2000","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0780","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-9-51","article-title":"Models of \u03b2-amyloid induced Tau-pathology: the long and \u201cfolded\u201d road to understand the mechanism","volume":"9","author":"Stancu","year":"2014","journal-title":"Mol. Neurodegener."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073303","article-title":"Interactions between A\u03b2 and mutated Tau lead to polymorphism and induce aggregation of A\u03b2-mutated tau oligomeric complexes","volume":"8","author":"Raz","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.bpc.2021.106735_bb0790","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1021\/acs.jpclett.5b01447","article-title":"A\u03b2 \u201cstretching-and-packing\u201d cross-seeding mechanism can trigger tau protein aggregation","volume":"6","author":"Qi","year":"2015","journal-title":"J. Phys. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bpc.2021.106735_bb0795","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/acschemneuro.5b00192","article-title":"Cross-seeding interaction between \u03b2-amyloid and human islet amyloid polypeptide","volume":"6","author":"Hu","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"35","key":"10.1016\/j.bpc.2021.106735_bb0800","doi-asserted-by":"crossref","first-page":"23245","DOI":"10.1039\/C5CP03329B","article-title":"Polymorphic cross-seeding amyloid assemblies of amyloid-\u03b2 and human islet amyloid polypeptide","volume":"17","author":"Zhang","year":"2015","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0805","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1021\/acs.jcim.5b00166","article-title":"Polymorphic associations and structures of the cross-seeding of A\u03b21\u201342 and hIAPP1\u201337 polypeptides","volume":"55","author":"Zhang","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0810","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acschemneuro.6b00247","article-title":"Molecular understanding of A\u03b2-hIAPP cross-seeding assemblies on lipid membranes","volume":"8","author":"Zhang","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2021.106735_bb0815","doi-asserted-by":"crossref","first-page":"106239","DOI":"10.1016\/j.bpc.2019.106239","article-title":"The pressure and temperature perturbation approach reveals a whole variety of conformational substates of amyloidogenic hIAPP monitored by 2D NMR spectroscopy","volume":"254","author":"Erlach","year":"2019","journal-title":"Biophys. Chem."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0820","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1039\/C5CP03338A","article-title":"Amylin\u2013A\u03b2 oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer\u2019s disease","volume":"18","author":"Baram","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0825","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1021\/acs.jpcb.0c11132","article-title":"Mechanistic insights into the Co-aggregation of A\u03b2 and hIAPP: an all-atom molecular dynamic study","volume":"125","author":"Li","year":"2021","journal-title":"J. Phys. Chem. B"},{"issue":"15","key":"10.1016\/j.bpc.2021.106735_bb0830","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1039\/D0TB02958K","article-title":"Dual amyloid cross-seeding reveals steric zipper-facilitated fibrillization and pathological links between protein misfolding diseases","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0835","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","article-title":"Interaction between A\u03b2 peptide and \u03b1 synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease","volume":"31","author":"Mandal","year":"2006","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0840","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/acschemneuro.5b00204","article-title":"Non-amyloid-\u03b2 component of human \u03b1-synuclein oligomers induces formation of new A\u03b2 oligomers: insight into the mechanisms that link Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"7","author":"Atsmon-Raz","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"50","key":"10.1016\/j.bpc.2021.106735_bb0845","doi-asserted-by":"crossref","first-page":"19423","DOI":"10.1523\/JNEUROSCI.2561-13.2013","article-title":"Mechanisms of transthyretin inhibition of \u03b2-amyloid aggregation in vitro","volume":"33","author":"Li","year":"2013","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0850","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1039\/C1CC14285B","article-title":"Co-assembly of human islet amyloid polypeptide (hIAPP)\/insulin","volume":"48","author":"Liu","year":"2012","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0855","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1021\/acschemneuro.9b00645","article-title":"Inhibitory activity of insulin on A\u03b2 aggregation is restricted due to binding selectivity and specificity to polymorphic A\u03b2 states","volume":"11","author":"Baram","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2021.106735_bb0860","doi-asserted-by":"crossref","first-page":"106507","DOI":"10.1016\/j.bpc.2020.106507","article-title":"Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology","volume":"269","author":"Ivanova","year":"2021","journal-title":"Biophys. Chem."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0865","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.chemrev.0c00981","article-title":"Proteostasis of islet amyloid polypeptide: a molecular perspective of risk factors and protective strategies for type II diabetes","volume":"121","author":"Milardi","year":"2021","journal-title":"Chem. Rev."},{"issue":"5","key":"10.1016\/j.bpc.2021.106735_bb0870","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1021\/acschemneuro.7b00396","article-title":"Islet amyloid polypeptide promotes amyloid-beta aggregation by binding-induced helix-unfolding of the amyloidogenic core","volume":"9","author":"Ge","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2021.106735_bb0875","doi-asserted-by":"crossref","first-page":"106631","DOI":"10.1016\/j.bpc.2021.106631","article-title":"Comparison of the force fields on monomeric and fibrillar PHF6 of tau protein","volume":"277","author":"Li","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2021.106735_bb0880","doi-asserted-by":"crossref","first-page":"106421","DOI":"10.1016\/j.bpc.2020.106421","article-title":"Structures of the intrinsically disordered A\u03b2, tau and \u03b1-synuclein proteins in aqueous solution from computer simulations","volume":"264","author":"Nguyen","year":"2020","journal-title":"Biophys. Chem."},{"issue":"46","key":"10.1016\/j.bpc.2021.106735_bb0885","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1039\/C9TB01871A","article-title":"Fundamentals of cross-seeding of amyloid proteins: an introduction","volume":"7","author":"Ren","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"17","key":"10.1016\/j.bpc.2021.106735_bb0890","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1021\/acschemneuro.1c00445","article-title":"Insights into the mechanistic perspective effect of insulin on the nonamyloidogenic component (NAC) and \u03b1-synuclein aggregation","volume":"12","author":"Abramov-Harpaz","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"18","key":"10.1016\/j.bpc.2021.106735_bb0895","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1039\/C8SC00481A","article-title":"Mechanistic perspective and functional activity of insulin in amylin aggregation","volume":"9","author":"Baram","year":"2018","journal-title":"Chem. Sci."},{"issue":"41","key":"10.1016\/j.bpc.2021.106735_bb0900","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1021\/acs.jpcb.6b07731","article-title":"Molecular mechanisms of the bindings between non-amyloid \u03b2 component oligomers and amylin oligomers","volume":"120","author":"Atsmon-Raz","year":"2016","journal-title":"J. Phys. Chem. B"},{"issue":"2\u20133","key":"10.1016\/j.bpc.2021.106735_bb0905","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jmb.2011.11.023","article-title":"Selective molecular recognition in amyloid growth and transmission and cross-species barriers","volume":"421","author":"Ma","year":"2012","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb0910","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.bpc.2021.106735_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.03.006","article-title":"Morphologic diagnosis of \u201cvascular dementia\u201d\u2014a critical update","volume":"270","author":"Jellinger","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0920","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction\u2014the disregarded partner of Alzheimer\u2019s disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"12","key":"10.1016\/j.bpc.2021.106735_bb0925","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/NEN.0000000000000016","article-title":"Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center","volume":"72","author":"Serrano-Pozo","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bpc.2021.106735_bb0930","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-pathol-020712-163927","article-title":"Emerging concepts in Alzheimer\u2019s disease","volume":"10","author":"Vinters","year":"2015","journal-title":"Ann. Rev. Pathol.: Mech. Dis."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb0935","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.2001.tb03522.x","article-title":"Fibrin and wound healing","volume":"936","author":"Clark","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0940","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neurobiolaging.2014.10.030","article-title":"Fibrin deposited in the Alzheimer\u2019s disease brain promotes neuronal degeneration","volume":"36","author":"Cortes-Canteli","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.bpc.2021.106735_bb0945","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.neuron.2010.05.014","article-title":"Fibrinogen and \u03b2-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer\u2019s disease","volume":"66","author":"Cortes-Canteli","year":"2010","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb0950","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.celrep.2014.07.028","article-title":"Nontranscriptional role of Hif-1\u03b1 in activation of \u03b3-secretase and notch signaling in breast cancer","volume":"8","author":"Villa","year":"2014","journal-title":"Cell Rep."},{"issue":"50","key":"10.1016\/j.bpc.2021.106735_bb0955","doi-asserted-by":"crossref","first-page":"21812","DOI":"10.1073\/pnas.1010373107","article-title":"Alzheimer\u2019s disease peptide \u03b2-amyloid interacts with fibrinogen and induces its oligomerization","volume":"107","author":"Ahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/j.bpc.2021.106735_bb0960","first-page":"3342","article-title":"A\u03b2 delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin","volume":"119","author":"Zamolodchikov","year":"2012","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0965","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1172\/JCI97509","article-title":"Blood will out: vascular contributions to Alzheimer\u2019s disease","volume":"128","author":"Strickland","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb0970","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/acs.biomac.9b01650","article-title":"Human plasma protein corona of A\u03b2 amyloid and its impact on islet amyloid polypeptide cross-seeding","volume":"21","author":"Nandakumar","year":"2020","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0975","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1021\/acsnano.8b02346","article-title":"Profiling the serum protein corona of fibrillar human islet amyloid polypeptide","volume":"12","author":"Pilkington","year":"2018","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb0980","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain\u2014implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb0985","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1179\/016164106X130506","article-title":"Update on hypertension and Alzheimer\u2019s disease","volume":"28","author":"Skoog","year":"2006","journal-title":"Neurol. Res."},{"issue":"12","key":"10.1016\/j.bpc.2021.106735_bb0990","first-page":"H1598","article-title":"The effects of hypertension on the cerebral circulation","volume":"304","author":"Pires","year":"2013","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb0995","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1113\/EP086434","article-title":"The role of the blood\u2013brain barrier in hypertension","volume":"103","author":"Setiadi","year":"2018","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb1000","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jcbfm.2015.79","article-title":"Hypertension enhances A \u03b2-induced neurovascular dysfunction, promotes \u03b2-secretase activity, and leads to amyloidogenic processing of APP","volume":"36","author":"Faraco","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"12","key":"10.1016\/j.bpc.2021.106735_bb1005","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1172\/JCI86950","article-title":"Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension","volume":"126","author":"Faraco","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb1010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","article-title":"Alzheimer\u2019s disease and vascular aging: JACC focus seminar","volume":"75","author":"Cortes-Canteli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.bpc.2021.106735_bb1015","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.0000000000002590","article-title":"Brain arterial aging and its relationship to Alzheimer dementia","volume":"86","author":"Gutierrez","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer\u2019s disease-lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb1025","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.3390\/ijms22094850","article-title":"Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer\u2019s disease","volume":"22","author":"Sharma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb1030","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"38","key":"10.1016\/j.bpc.2021.106735_bb1035","doi-asserted-by":"crossref","first-page":"15301","DOI":"10.1073\/pnas.1305462110","article-title":"Age-dependent dissociation of ATP synthase dimers and loss of inner-membrane cristae in mitochondria","volume":"110","author":"Daum","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bpc.2021.106735_bb1040","first-page":"347","article-title":"Pathogenesis of Alzheimer\u2019s disease","volume":"2","author":"Swerdlow","year":"2007","journal-title":"Clin. Interv. Aging"},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb1045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/arclin\/acu016","article-title":"Mitochondrial DNA mutations and cognition: a case-series report","volume":"29","author":"Inczedy-Farkas","year":"2014","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kft102","article-title":"Mitochondria as a target of environmental toxicants","volume":"134","author":"Meyer","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb1055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-013-1190-x","article-title":"The neuropathology of obesity: insights from human disease","volume":"127","author":"Lee","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.bpc.2021.106735_bb1060","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1073\/pnas.0511154103","article-title":"Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology","volume":"103","author":"Yu","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb1065","article-title":"A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons","volume":"7","author":"Fessel","year":"2021","journal-title":"Alzheimer's Dementia: Translat. Res. Clin. Intervent."},{"key":"10.1016\/j.bpc.2021.106735_bb1070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jprot.2016.03.022","article-title":"Identification of proteins that are differentially expressed in brains with Alzheimer\u2019s disease using iTRAQ labeling and tandem mass spectrometry","volume":"139","author":"Minjarez","year":"2016","journal-title":"J. Proteome"},{"issue":"5713","key":"10.1016\/j.bpc.2021.106735_bb1075","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bpc.2021.106735_bb1080","doi-asserted-by":"crossref","first-page":"316523","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer\u2019s disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bpc.2021.106735_bb1085","first-page":"36","article-title":"Role of metals in Alzheimer\u2019s disease","volume":"2021","author":"Das","year":"1627","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-020-00189-z","article-title":"Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Wang","year":"2020","journal-title":"Translat. Neurodegenerat."},{"issue":"9","key":"10.1016\/j.bpc.2021.106735_bb1095","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jmb.2019.01.018","article-title":"Metal toxicity links to Alzheimer\u2019s disease and neuroinflammation","volume":"431","author":"Huat","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bpc.2021.106735_bb1100","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.accounts.9b00248","article-title":"Metal ions in Alzheimer\u2019s disease: a key role or not?","volume":"52","author":"Liu","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb1105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1039\/C6CS00731G","article-title":"Towards an understanding of amyloid-\u03b2 oligomers: characterization, toxicity mechanisms, and inhibitors","volume":"46","author":"Lee","year":"2017","journal-title":"Chem. Soc. Rev."},{"issue":"4","key":"10.1016\/j.bpc.2021.106735_bb1110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12017-014-8328-4","article-title":"Multiple mechanisms of iron-induced amyloid beta-peptide accumulation in SHSY5Y cells: protective action of negletein","volume":"16","author":"Banerjee","year":"2014","journal-title":"NeuroMolecular Med."},{"issue":"5a","key":"10.1016\/j.bpc.2021.106735_bb1115","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1582-4934.2008.00356.x","article-title":"A potential pathogenetic role of iron in Alzheimer\u2019s disease","volume":"12","author":"Silvestri","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb1120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuint.2012.12.005","article-title":"Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain","volume":"62","author":"Guo","year":"2013","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb1125","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/ijms18061117","article-title":"Mammalian metallothionein-3: new functional and structural insights","volume":"18","author":"Va\u0161\u00e1k","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bpc.2021.106735_bb1130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-export ferroxidase activity of \u03b2-amyloid precursor protein is inhibited by zinc in Alzheimer\u2019s disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb1135","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1523\/JNEUROSCI.4386-03.2004","article-title":"Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer\u2019s-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability","volume":"24","author":"Stutzmann","year":"2004","journal-title":"J. Neurosci."},{"issue":"16","key":"10.1016\/j.bpc.2021.106735_bb1140","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1073\/pnas.89.16.7683","article-title":"Magnetite biomineralization in the human brain","volume":"89","author":"Kirschvink","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb1145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2006.04.003","article-title":"A new insight on Al-maltolate-treated aged rabbit as Alzheimer\u2019s animal model","volume":"52","author":"Shamasundar","year":"2006","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.bpc.2021.106735_bb1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2021.106735_bb1155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2016.12.045","article-title":"Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, A\u03b21\u201342 aggregation inhibitors and metal-chelating agents for Alzheimer\u2019s disease","volume":"127","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bpc.2021.106735_bb1160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462221002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462221002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:42:23Z","timestamp":1778506943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462221002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":232,"alternative-id":["S0301462221002180"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2021.106735","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mechanistic survey of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2021.106735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106735"}}